Monday 15 December | 10:25:54 Europe / Stockholm

Subscription

Calendar

Est. time*
2026-11-12 07:00 Quarterly Report 2026-Q3
2026-08-19 07:00 Quarterly Report 2026-Q2
2026-05-14 07:00 Quarterly Report 2026-Q1
2026-04-23 N/A Annual General meeting
2026-02-19 07:00 Year-end Report 2025
2026-01-02 N/A Extra General Meeting 2026
2025-11-12 - Extra General Meeting 2025
2025-11-12 - Quarterly Report 2025-Q3
2025-08-20 - Quarterly Report 2025-Q2
2025-05-15 - Quarterly Report 2025-Q1
2025-04-28 - Ex-date Ordinary Dividend LIFE 0.00 NOK
2025-04-25 - Annual General meeting
2025-02-20 - Year-end Report 2024
2024-11-13 - Quarterly Report 2024-Q3
2024-10-01 - Split LIFE 13:1
2024-08-27 - Quarterly Report 2024-Q2
2024-05-16 - Extra General Meeting 2024
2024-05-08 - Quarterly Report 2024-Q1
2024-05-02 - Ex-date Ordinary Dividend LIFE 0.00 NOK
2024-04-30 - Annual General meeting
2024-02-27 - Year-end Report 2023
2023-11-14 - Quarterly Report 2023-Q3
2023-08-23 - Quarterly Report 2023-Q2
2023-05-11 - Quarterly Report 2023-Q1
2023-05-08 - Ex-date Ordinary Dividend LIFE 0.00 NOK
2023-04-18 - Annual General meeting
2023-02-28 - Year-end Report 2022
2022-08-25 - Quarterly Report 2022-Q2
2022-05-09 - Ex-date Ordinary Dividend LIFE 0.00 NOK
2022-05-06 - Annual General meeting
2022-04-21 - Year-end Report 2021
2021-09-30 - Extra General Meeting 2021
2021-08-05 - Quarterly Report 2021-Q2
2021-05-10 - Ex-date Ordinary Dividend LIFE 0.00 NOK
2021-05-07 - Annual General meeting
2021-04-20 - Year-end Report 2020
2020-06-26 - Annual General meeting
2020-06-01 - Year-end Report 2019
2019-02-07 - Split LIFE 4:1
2018-12-11 - Extra General Meeting 2018

Description

CountryNorway
ListOslo Bors
SectorHealth care
IndustryMedical technology
Lifecare is a Norwegian company operating in medical technology. The company specializes in research and development of solutions for diabetes. The microsensors are injected under the skin of the patient's wrist, and also function as a real-time update of the patient's glucose level. In addition, the technology provides an alarm sensor and access to historical data on the patient's glucose level. The company was established in 2006 and is headquartered in Bergen, Norway.

Interested in the company’s key figures?

Analyze the company in Börsdata!

Who owns the company?

Find all ownership data in Holdings!

2023-12-19 08:00:00

Professor Dr. Tony James will join Lifecare's Scientific Advisory Board. - We have collaborated with Professor Tony James since 2019, and we are really excited to bring him on board in this position, says CEO Joacim Holter.

Tony James is professor of Chemistry at the University of Bath and Fellow of the Royal Society of Chemistry. He has received the Daiwa-Adrian Prize for developing scientific links with Japan, the CASE Prize for establishing scientific networks with China, the MSMLG Czarnik Award, the Frontiers in Chemistry Diversity Award and a Royal Society Wolfson Research Merit Award. He is also listed by Clarivate as a Highly Cited Researcher in Chemistry.

– Tony James has an outstanding academic record. He has published over 470 publications, including three books, 10 book chapters and 457 papers in international peer reviewed journals. Professor James is also the named inventor on 30 international patents and has delivered 266 invited lectures within the UK and internationally. He is a remarkable asset for Lifecare, Holter points out.

The CEO of Lifecare states that he is very pleased that Prof James will now add valuable insight within his area of expertise to our highly competent Scientific Advisory Board.

Lifecare's Scientific Advisory Board is chaired by the distinguished Prof. David C. Klonoff: https://lifecare.no/about-lifecare/#scientificadv